Skip to main content

Relugolix Side Effects

Medically reviewed by Drugs.com. Last updated on Nov 6, 2023.

Applies to relugolix: oral tablet.

Serious side effects of Relugolix

Along with its needed effects, relugolix may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking relugolix:

Less common

Rare

Incidence not known

Other side effects of Relugolix

Some side effects of relugolix may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to relugolix: oral tablet.

Hematologic

Very common (10% or more): Decreased hemoglobin (28%)

Uncommon (0.1% to 1%): hemorrhage (0.3%)[Ref]

Musculoskeletal

Very common (10% or more): Musculoskeletal pain (30%)

Uncommon (0.1% to 1%): Fracture (0.3%)[Ref]

Metabolic

Very common (10% or more): Increased glucose (44%), increased triglycerides (35%)

Common (1% to 10%): Increased weight[Ref]

Psychiatric

Common (1% to 10%): Insomnia, depression, decreased libido[Ref]

Genitourinary

Uncommon (0.1% to 1%): Urinary tract infection (0.5%)[Ref]

Hepatic

Very common (10% or more): Increased alanine aminotransferase (27%), increased aspartate aminotransferase (18%)[Ref]

Oncologic

Uncommon (0.1% to 1%): Metastatic lung cancer (0.3%)[Ref]

Respiratory

Uncommon (0.1% to 1%): Pneumonia (0.3%)[Ref]

General

Very common (10% or more): Fatigue (26%)[Ref]

Renal

Uncommon (0.1% to 1%): Acute kidney injury up to 0.6%), urinary tract infection (0.5%)[Ref]

Cardiovascular

Uncommon (0.1% to 1%): Myocardial infarction (up to 0.8%), arrhythmia (0.6%), atrioventricular block (0.3%), cardiac failure (0.3%)

Frequency not reported: Fatal and non-fatal myocardial infarction, stroke[Ref]

Dermatologic

Common (1% to 10%): Hyperhidrosis[Ref]

Endocrine

Very common (10% or more): Hot flash (54%)

Common (1% to 10%): Gynecomastia[Ref]

Gastrointestinal

Very common (10% or more): Constipation (12%), diarrhea (12%)

Uncommon (0.1% to 1%): Abdominal pain (0.3%)[Ref]

References

1. Product Information. Orgovyx (relugolix). Myovant Sciences, Inc. 2021.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.